SUMMARY Restriction fragment length polymorphisms (RFLPs) within or close to the factor VIII locus are very useful for genetic linkage analysis. Such RFLPs allow a mutant allele to be tracked in a family, segregating haemophilia A even when, as is usually the case, the precise mutation causing failure to synthesise factor VIII is unknown. To date two markers tightly linked to the factor VIII locus have been described, one of which is highly polymorphic and therefore informative in most kindreds. A significant crossover rate, however, does not make diagnosis absolute. Three intragenic RFLPs have been defined, which, taken together, are informative in about 70% of women, providing virtually deterministic genetic diagnosis.
Diagnosis of the carrier state is an urgent clinical problem in families with a known case ofhaemophilia A. For every affected male, on average eight female relatives will be found who have a greater or lesser genetic risk of carrying the mutant allele. Risk assessment was based until recently on pedigree analysis combined with factor VIII and Von Willebrand factor antigen assays.' At best, about 85% accuracy of discrimination from the phenotype assays was obtained. As a result many females at relatively low risk opted for definitive antenatal diagnosis by means of factor VIII bioassay or antigen assay of fetoscopic blood sample taken in the second trimester. 2 The introduction of linkage analysis based on the use of intragenic DNA probes and linked DNA markers has greatly improved definitive diagnosis. 3 In this paper we describe the DNA probes available for diagnosis of haemophilia A and give examples of their use in families studied over the past two years.
Material and methods
Families with at least one confirmed case of haemophilia A were referred for genetic counselling to the Haemophilia Centre, Royal Free Hospital, by physicians from the United Kingdom and world wide. Local residents attended in person for counselling and to give blood samples. Some blood and chorion biopsy samples were taken by the referring centre and shipped as whole blood or tissue frozen on dry ice. SEPARATION 0 10 20 30 40 50 60 7 80 90 100 110 120 130 140 150 160 170 180 190 200   I   I-I-I   I II I   I  I  I  I   I  I  I  I  I  I  I   23 
Results
The reported incidence of the alleles for intragenic and linked RFLP's varies somewhat according to population and sample size. Table 1 gives percentages based on our own series of mainly northern European ancestry. The largest discrepancy was the frequency of alleles at the factor VIII 3'BglI site'2 between European and AfroCaribbean patients. In Europeans about 80% of X chromosomes have this site-that is, 5 kb allele detected-in blacks the frequency is 74%, giving a higher expected heterozygosity rate for females. The cumulative heterozygosity for the three intragenic RFLPs was not additive due to linkage disequilibrium: the time elapsed from the mutation events responsible for the DNA variations was not long enough to allow sufficient meiotic crossovers to randomise the distribution of alleles on all chromosomes. Table 2 gives haplotypes for BclI and XbaI. The haplotype -/ + (large fragment/small fragment) was rare or absent. This means that women homozygous for BclI -are not informative for XbaI either because they will be homozygous for XbaI -. Fortunately, BclI + is the common allele, and such homozygous women (60%) have a 37-5% (2 x 0 75 x 0-25 x 100) chance of being heterozygous for XbaI. Table  3 gives the haplotypes for BclI and BglI. The chance of being heterozygous for both is reduced as the common allele BclI + is associated with the common allele BglI +. Only those rare females who are homozygous for BclI + (4%) can get additional information from BglI. The net effect of these imbalances is that about 70% of European females are informative-that is, Carrier detection and perpetual diagnosis of haemophilia A heterozygous-at one or more polymorphic intragenic sites. These women can be given firm genetic advice based on linkage as the risk of crossover between these markers and a putative mutation must average about 0-1% per meiosis. The total length of the factor VIII gene is about 200 kb or 02cM. 16 The maximum distance from marker to mutation (fig 1) is 130kb or about 0 -cM, equivalent to a 1/1000 crossover rate per meiosis.
For 30% of women who are non-informative with intragenic RFLPs we must resort to linked markers. Stl4 and DX1 3 are at a small but important map distance from factor VIII. Table 4 therefore be counselled on that basis and can have first trimester fetal diagnosis using either the factor VIII BclI or the factor VIII XbaI RFLPs. This case shows the importance of maintaining the phenotype assays (VIII:c and VWF:Ag) as combining information of phenotype and linkage enhances diagnostic potential.
The families in which a single case of haemophilia has occurred at time of consultation (so called sporadic cases) present a different problem-that of determining the level of the mutation, which can be presumed to be of recent origin. Fig 4 illustrates the power of linkage analysis in such a kindred. A single haemophiliac III2 has the haplotype 11/6 2/2 8. This is identical with the haplotype of one X chromosome of his aunt 115 who was the "consultand." This X chromosome, however, must have come from the haemophiliac's normal grandfather I1. Therefore a new mutation had occurred either at spermatogenesis from I, or at oogenesis from II2. In both cases IIs is excluded from carriership. Further information about the status of II2 could be obtained from phenotype analysis or by testing the haplotype of III1.
Even in families with no living haemophiliac, linkage analysis is often helpful provided that the diagnosis of the deceased patients was definitive. Fig 5 shows such a family: although 113 and III2 had died, the survival of a normal male I113 enabled predictions to be made from his two sisters III, and I114 who have a 50% chance of carriership on pedigree. Clearly the 6-2kb allele must be associated with haemophilia. Therefore III1 is a carrier and I114 is not.
In the family shown in fig 6 the "consultand's" father I1 had died years ago in Zimbabwe and no other affected relatives were available. A blood sample was flown over to us from I2 (her mother in South Africa), and by comparing haplotypes it can be inferred that the haemophilic X chromosome bears 974 i.1.1 n.st
Carrier detection and perpetual diagnosis of haemophilia A the 4-8 kb allele. As II, is heterozygous for this RFLP she can be offered antenatal diagnosis.
The family shown in fig 7 combine the problems addressed in the two preceding cases with a requirement for antenatal diagnosis of a male fetus (O). Comparison of alleles of I2 and 112 showed that 112 had inherited the 1 1 kb allele from her haemophilic father (the phenotype results merely confirm that she is an obligate carrier of haemophilia A). A chorion biopsy specimen obtained at eight weeks' gestation from III1 was shown to be male on karyotype. Fetal DNA was extracted5 and shown to bear the 0-8 allele.
The pregnancy was therefore allowed to continue as the fetus would be normal.
In fig 8 the analysis was performed to help an obligate carrier (II12) in future pregnancies. A haemophilic fetus (IV1) was diagnosed by fetoscopic F Vill Bcl I Vill: C 37 u/dl VWF: Ag 100 u/dI II III blood sampling at 18 weeks and terminated. The patient was non-informative for factor VIII BclI but informative for Stl4TaqI. The allele number 4 segregates with haemophilia in this family and therefore can be used for antenatal diagnosis, provided a predicted normal male at 18 weeks' gestation is checked by blood sample in case of error due to crossover.
The kindred analysed in fig 9 shows the benefit of using two independent intragenic markers. The consultand (II13) was pregnant when she requested diagnosis. A haemophilic uncle (II7) was available for Therefore III3 is not a carrier and the pregnancy was allowed to continue undisturbed by any sampling.
Discussion
Availability of intragenic and linked RFLPs for genetic diagnosis of haemophilia A has greatly enhanced our ability to establish definitively carrier status. It is now also possible to perform antenatal diagnosis by linkage analysis using DNA extracted from chorion villus tissue as early as eight weeks' gestation. Several problems remain. As yet available intragenic markers are informative in only 70% of women. There is a need to identify more RFLPs within and flanking the factor VIII gene. To date, only about 15% of the gene has been screened for polymorphism,8 11 and it is highly likely more remain to be discovered. As families are often incomplete and some haemophiliacs die young it is essential to retain the phenotype assays, as pointed out by Graham et al.21
Certain difficulties of linkage analysis are inherent and can only be contained by vigilance and attention to detail, bearing in mind that paternity may not always be as stated. Table 5 lists some of these problems. In addition, the costs of analyses entailing DNA manipulation are high. Against these costs should be set the considerable improvement in the genetic counselling service to potential carriers, and in the long 
